Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Other Accumulated Expenses (2024 - 2025)

Historic Other Accumulated Expenses for Coeptis Therapeutics Holdings (COEPW) over the last 2 years, with Q3 2025 value amounting to $120000.0.

  • Coeptis Therapeutics Holdings' Other Accumulated Expenses changed N/A to $120000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $120000.0, marking a year-over-year change of. This contributed to the annual value of $235000.0 for FY2024, which is N/A changed from last year.
  • Per Coeptis Therapeutics Holdings' latest filing, its Other Accumulated Expenses stood at $120000.0 for Q3 2025.
  • Coeptis Therapeutics Holdings' Other Accumulated Expenses' 5-year high stood at $235000.0 during Q4 2024, with a 5-year trough of $120000.0 in Q3 2025.